Scientific Conclave on Indian Pharmacopoeia Held in Haridwar

The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 “Strengthening Pharmaceutical Manufacturing through Pharmacopoeial Standards and Quality Compliance” at Haridwar yesterday, in collaboration with the Association of Devbhumi Pharma Industries (ADPI) and affiliated pharmaceutical manufacturing associations of Uttarakhand. The conclave was organized with the objective of enhancing awareness on the provisions of IP 2026 and promoting quality compliance across the pharmaceutical manufacturing sector.

The programme brought together representatives from pharmaceutical manufacturing units, quality control and quality assurance professionals, regulatory authorities, analytical scientists, and drug testing laboratory personnel to deliberate on recent developments in pharmacopoeial standards and their implementation in the pharmaceutical industry.

The inaugural session commenced with a welcome address by Sandeep Jain, Chairman, ADPI. Addressing the gathering, he emphasized the importance of collaboration between industry and standard-setting bodies in strengthening pharmaceutical quality systems.

The session was also addressed by Sidharth Sahai Malhotra, Assistant Drugs Controller (India), CDSCO, Dehradun, and Tajber Singh, Drug Controller and State Licensing Authority, Uttarakhand, who highlighted the critical role of pharmacopoeial standards in ensuring regulatory compliance and safeguarding public health.(upated on 11th June 2026)